Skip to main content

Emerging Paradigms and Future Directions

EPF-05 - Beyond the Pill: Precision, Technology, and Multimodal Strategies to Transform Pain Care

Friday, September 11, 2026
9:35 AM - 10:25 AM PDT

    Co-Presenter(s)

  • Christopher G. Gharibo, MD

    Medical Director of Pain Medicine, NYU Langone Health
    Professor, Department of Anesthesiology, Perioperative Care & Pain Medicine Professor, Department of Orthopedics; NYU Grossman School of Medicine
    NYU Grossman School of Medicine
    NY, New York

  • Paul J. Christo, MD, MBA

    Chief, Division of Pain Medicine
    Johns Hopkins Medicine
    Baltimore, Maryland

  • Robert B. Raffa, PhD

    (1) Emeritus Prof (2) Adjunct Prof
    (1) Temple Univ (2) Univ AZ College Pharmacy
    Temple University
    Tucson, Arizona

  • Joseph V. Pergolizzi, Jr., MD, MBA

    Chief of Research and Development
    Naples Anesthesia and Pain Associates
    Naples, Florida

Chronic pain remains a leading cause of disability worldwide, yet traditional treatment models often fail to deliver durable outcomes. This interactive, evidence-based session introduces a modern framework for precision pain care integrating FDA-approved non-opioid pharmacotherapies, neuromodulation and interventional strategies, validated behavioral therapies, and emerging digital health tools.

Participants engage in immersive case simulations representing diverse populations, including older adults and underserved patients. Live polling and adaptive decision pathways guide learners through guideline-concordant decision-making grounded in systematic reviews and current clinical practice standards. Faculty review recent advances in non-opioid therapeutics, neuromodulation, and digital monitoring, emphasizing balanced risk–benefit analysis and patient safety.

Learning Objectives:

  • Apply evidence-based multimodal strategies integrating pharmacologic, interventional, behavioral, and digital approaches.
  • Evaluate FDA-approved non-opioid and neuromodulation therapies using current evidence and regulatory status.
  • Incorporate digital health tools into individualized treatment planning.
  • Tailor pain care for diverse populations to reduce disparities and improve outcomes.